DCM
LMAT icon

Driehaus Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Driehaus Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-197,225
Closed -$21.5M – 403
2026
Q1 		$21.5M Buy
+197,225
New +$18.8M 0.16% 194
2025
Q2 		– Sell
-154,006
Closed -$12.9M – 467
2025
Q1 		$12.9M Sell
154,006
-109,214
-41% -$10.2M 0.12% 207
2024
Q4 		$24.3M Sell
263,220
-2,988
-1% -$287K 0.2% 153
2024
Q3 		$24.7M Buy
266,208
+1,991
+0.8% +$173K 0.21% 141
2024
Q2 		$21.7M Buy
264,217
+90,573
+52% +$6.65M 0.21% 140
2024
Q1 		$11.5M Buy
173,644
+76,656
+79% +$4.73M 0.11% 225
2023
Q4 		$5.51M Sell
96,988
-23,903
-20% -$1.25M 0.07% 264
2023
Q3 		$6.59M Buy
120,891
+17,982
+17% +$1.07M 0.09% 264
2023
Q2 		$6.92M Buy
+102,909
New +$6.28M 0.09% 256
2018
Q1 		– Sell
-112,069
Closed -$3.57M – 544
2017
Q4 		$3.57M Sell
112,069
-58,603
-34% -$2.01M 0.14% 196
2017
Q3 		$6.39M Sell
170,672
-31,680
-16% -$1.08M 0.25% 110
2017
Q2 		$6.32M Sell
202,352
-48,343
-19% -$1.4M 0.23% 99
2017
Q1 		$6.17M Sell
250,695
-268,347
-52% -$6.3M 0.21% 106
2016
Q4 		$13.2M Buy
519,042
+7,646
+1% +$170K 0.47% 36
2016
Q3 		$10.1M Buy
511,396
+101,555
+25% +$1.77M 0.34% 63
2016
Q2 		$5.85M Sell
409,841
-185,941
-31% -$2.84M 0.21% 108
2016
Q1 		$9.25M Sell
595,782
-3,189
-0.5% -$45.7K 0.3% 64
2015
Q4 		$10.3M Buy
598,971
+51,986
+10% +$752K 0.35% 67
2015
Q3 		$6.67M Buy
546,985
+282,302
+107% +$3.62M 0.24% 102
2015
Q2 		$3.19M Buy
+264,683
New +$2.61M 0.11% 239

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Driehaus Capital Management's LMAT Position: Q2 2026 in Review

Driehaus Capital Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 197,225 shares — an estimated $21.5M sold.

Driehaus Capital Management first reported a position in LMAT in Q2 2015 and held it in 20 quarters. The position peaked at $24.7M in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Driehaus Capital Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 197,225 LeMaitre Vascular shares in Q2 2026, an estimated $21.5M.
  • Driehaus Capital Management first reported a position in LeMaitre Vascular in Q2 2015 and held it in 20 quarters.
  • Driehaus Capital Management's LeMaitre Vascular position peaked at $24.7M in Q3 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.